Innopharma

What Innopharma does

Innopharma s.r.o. is a Slovak contract development and manufacturing organisation (CDMO) founded in February 2008 and headquartered in Dunajská Streda, Slovakia, with approximately 140 employees. The company specialises in the development and production of vitamin, mineral, and dietary supplement tablets in three flagship dosage forms: effervescent, chewable and swallow, and dextrose tablets, supplied under customers' own brands through private-label and contract-manufacturing arrangements. Its customers include large European retailers, drugstores, food retailers, discounters, pharmacy wholesalers and chains, consumer-healthcare brand manufacturers, wholesalers/distributors, and B2C online retailers. Innopharma has been a wholly owned subsidiary of the Hamburg-based EVP Group since 2020, operating alongside sister subsidiaries in Germany (Euro Vital Pharma), the UK (Principle Healthcare), and Spain (Korott); together the group supplies approximately 95 million units per year across roughly 1,400 SKUs to over 100 B2B customers in 40+ countries.

The company's technology base centres on a modern Slovak tablet-manufacturing facility with automated packaging lines (tablet counting, shrink wrapping, ink-jet printing, metal detection, label application) supported by an in-house team of professional formulation chemists. R&D output stands at more than 2,300 developed formulations, 350+ approved effervescent formulations, 400+ approved chewable and dextrose formulations, and 250+ approved raw materials. Proprietary flavour-masking expertise for bitter or metallic nutrients using exclusively natural colours and flavours is positioned as a core differentiator. Quality assurance is anchored by BRC Global Food Standard (higher level), IFS Food, GMP for Food, RSPO (Mass Balance), and ISO 14001 environmental management certifications, with compliance to EU Directive and Council for Responsible Nutrition guidelines.

Innopharma monetises through quote-based B2B contract manufacturing, contract packaging, and private-label production services, with Euro-denominated pricing, 28-day quotation validity, net-30 payment terms, and +/-10% delivery tolerance. Standard lead times of 10 weeks for first delivery and 8 weeks for repeat orders are supported by a low minimum order quantity policy. The go-to-market is sales-led enterprise direct sales targeting large accounts, with worldwide export enabled through the EVP Group's cross-subsidiary distribution network; no direct-to-consumer storefront is operated. Revenue is not publicly disclosed.

Name

Innopharma

Legal name

Innopharma s.r.o.

Website

https://innopharma.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Innopharma s.r.o. is a Slovak CDMO and private-label manufacturer founded in 2008 that produces vitamin, mineral, and dietary supplement tablets (effervescent, chewable, dextrose) for European retailers, pharmacy chains, and brand manufacturers. The company operates as a subsidiary of the Hamburg-based EVP Group.

Ownership category

akta.pro rank

Product category

Nutraceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

Keywords

• Contract manufacturing services
• Dietary supplements manufacturing
• Private label vitamins
• Effervescent tablet production
• Food supplements CDMO

Headquarters

HQ city

Dunajská Streda

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Contract Manufacturing (CDMO): Manufacture of finished goods/bulk to customer specifications, including custom formulations and contract production of vitamins, minerals, and food supplements for retailers, pharmacy chains, and industrial brands.
2. Contract Packaging Services: Automated co-manufacturing packaging services for customers, including packaging design, sourcing, and final delivery. Performed on automated lines with full product traceability and batch code management.
3. Private Label Manufacturing: Production of food supplements (vitamins, minerals, effervescent and chewable tablets, dextrose) under customers' own brands for retailers, pharmacies, and brand manufacturers. Approximately 400 SKUs supplied to some of the world's largest retailers.
4. Product Development / R&D Services: Custom formulation development including R&D work and hand samples, supported by more than 2,300 developed formulations and expertise in effervescent, chewable, and dextrose tablet formats.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

Innopharma s.r.o. is a Slovak B2B contract development and manufacturing organization (CDMO) that develops, produces, and packages vitamin, mineral, and food-supplement tablets (effervescent, chewable/swallow, and dextrose) under customers' own brands. The company delivers an end-to-end full-service offering spanning custom formulation R&D, contract manufacturing of finished goods and bulk, automated contract packaging, and private-label supply for retailers, pharmacy chains, and brand manufacturers across Europe and worldwide.

Product overview

Innopharma operates a single integrated CDMO/private-label manufacturing platform rather than a software product suite. Its core offering is tablet-based food supplements, delivered through three flagship manufactured dosage forms — Effervescent Tablets, Chewable and Swallow Uncoated Tablets, and Dextrose Tablets — which together account for nearly 400 SKUs produced in Dunajská Streda, Slovakia. These dosage forms are delivered through a set of closely linked service modules: Product Development (R&D and custom formulation), Contract Manufacturing (CDMO) of finished goods and bulk, Contract Packaging on automated lines, and Private Label supply for retailers, pharmacy chains and brand manufacturers. The full stack is unified under Innopharma's parent EVP Group brand portfolio, which extends Innopharma's capabilities with alternative dosage forms such as capsules, liquids, gels and herbal products from group sister companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Effervescent Tablets Innopharma's flagship dosage form — effervescent vitamin, mineral, and food-supplement tablets in a standard 4g size with an extensive range of flavours, supplied in printed plastic tubes (offset, IML, or digital printing) and secondary packaging in single cartons, twin/triple packs, displays, plastic trays, and shippers. Offered as part of CDMO/private-label services to retailers, pharmacy chains, and brand manufacturers.
• Chewable and Swallow Uncoated Tablets Single- or multi-active chewable and swallow uncoated tablets produced in round (7.5–20 mm diameter) and oblong/oval formats with or without break line, available in sugar-free and natural colour/flavour variants. Fun formats include bear-shaped tablets or round tablets with smiling-sun imprints for children. Packaged in various plastic tubs with secondary boxes, displays, plastic trays, and shippers. Offered as part of CDMO/private-label services.
• Dextrose Tablets Pure dextrose tablets or dextrose tablets containing single or multiple active ingredients, packed in twist-end rolls of 17 round tablets or wrapped packs of 14 rectangular tablets, with secondary packaging in printed displays of 18, 27, or 108 rolls or 24/40 wrapped packs. Offered as part of CDMO/private-label services.
• Product Development (R&D and Custom Formulation) Tablet R&D service staffed by professional formulation chemists and technical assistants that develops innovative products and custom formulations for B2B customers, including hand samples and short R&D lead times. Customers can co-develop an individual solution from idea to shelf or select from Innopharma's standard formulations.
• Contract Manufacturing (CDMO) Finished-goods and bulk contract-manufacturing service for retailers, pharmacy chains, and industrial brands, offering low minimum order quantities, customised formulations, and contract-manufacturing agreements to the customer's recipe. Standard lead time is 10 weeks for first delivery and 8 weeks for repeated orders.
• Contract Packaging Automated co-manufacturing packaging service with multiple lines producing thousands of packed tablets per week, including tablet counting, automatic shrink wrappers, ink jet printing, metal detection, and automatic label applicators. Provides full product traceability, batch code management, and system-generated production reports with inventory and order-progress visibility.
• Private Label Supply Market-ready vitamin, mineral, and food-supplement products supplied under the customer's own brand, covering effervescent, chewable, and dextrose tablet formats with low MOQs and worldwide export support.

Quantifiable outcome

• Standard lead time of 10 weeks for first delivery and 8 weeks for repeated orders
• +4 more outcomes

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered flagship / core, core and minor.

• EVP Group (Euro Vital Pharma Group)flagship / coreStrategic or Co-development Partner · 1 January 2020Parent group of Innopharma s.r.o. since 2020. EVP Group was founded in 2020 to combine expertise and resources of medium-sized Consumer Healthcare and Wellbeing specialists with subsidiaries in Germany (Euro Vital Pharma), UK (Principle Healthcare), Slovakia (Innopharma), and Spain (Korott). The group enables Innopharma to access broader capabilities across dosage forms (capsules, liquids, gels, herbal products), shared procurement synergies, diversified product portfolio, and international reach across 40+ countries.
• Euro Vital Pharma GmbH (Hamburg, Germany)flagship / coreStrategic or Co-development PartnerSister subsidiary of Innopharma within the EVP Group. Euro Vital Pharma GmbH is the German market leader for private labels in consumer healthcare. Acts as the data controller and address of record for the Innopharma privacy policy. Together with Innopharma, it forms part of the group's integrated private label and CDMO offering.
• Principle Healthcare (Skipton, UK)coreStrategic or Co-development PartnerSister subsidiary of Innopharma within the EVP Group, based in Skipton, UK. One of four EVP Group subsidiaries operating independently under the group umbrella, contributing to the group's reach across European and international consumer healthcare markets.
• Korott (Alcoy, Spain)coreStrategic or Co-development PartnerSister subsidiary of Innopharma within the EVP Group, based in Alcoy, Spain. One of four EVP Group subsidiaries operating independently under the group umbrella, complementing Innopharma's CDMO and private label capabilities with regional presence in Southern Europe.
• Council for Responsible Nutrition (CRN)minorOthersIndustry membership — all Innopharma products comply with the Council for Responsible Nutrition guidelines. Innopharma is referenced as a member of the Council on its About Us page.
• Roundtable on Sustainable Palm Oil (RSPO)minorOthersSupply-chain sustainability certification partnership. Innopharma produces vitamins, minerals and food supplements using RSPO certified palm oil derivates under the MB module and holds the corresponding RSPO certificate.
• heyData GmbH (Berlin, Germany)minorImplementation/ SI/ Consulting PartnerExternal data protection officer service provider for Euro Vital Pharma GmbH / Innopharma. Located at Schützenstraße 5, 10117 Berlin, Germany. Handles data protection compliance (DS-GVO) for the Innopharma website.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Temmler Pharma (Aenova Group subsidiary): German CDMO with significant effervescent and solid-dose capability acquired by Aenova; directly comparable to Innopharma's flagship effervescent tablet offering but at substantially larger scale within a broader portfolio.
• Catalent: Global CDMO with European operations providing softgel, tablet, capsule, and other consumer health manufacturing services; competes with Innopharma for private-label supplement business but at a materially larger scale and with broader format depth.
• Salutas Pharma (Sandoz/Novartis group): Large German generics and consumer health manufacturer offering contract and private-label production of solid dosage forms including effervescent tablets; overlaps with Innopharma's core dosage forms but at significantly greater scale.
• Aenova Group: One of Europe's largest pharmaceutical and nutraceutical CDMOs with broad dosage-form capability (tablets, capsules, softgels, liquids); competes with Innopharma for the same retailer and brand private-label business but at significantly larger scale and with broader format coverage.

Direct peers

• Euro Vital Pharma GmbH: Innopharma's sister subsidiary within the EVP Group and the group's German private-label consumer healthcare market leader; both operate as CDMOs and private-label suppliers of vitamins, minerals, and food supplements to retailers, pharmacies, and brand manufacturers.
• Hermes Arzneimittel: German pharmaceutical and dietary supplement manufacturer with a strong private-label offering for vitamins and minerals; competes directly with Innopharma for European retail and pharmacy chain private-label contracts.
• Principle Healthcare: EVP Group sister subsidiary in the UK, focused on private-label and contract manufacturing of vitamins, minerals, and supplements; same group business model and customer base as Innopharma.
• Korott: EVP Group sister subsidiary based in Alcoy, Spain, providing CDMO and private-label services for consumer health and food supplements; directly comparable in business model to Innopharma but serving Southern Europe.
• Vitaquest International: US-based CDMO specializing in dietary supplement and nutritional product development, contract manufacturing and packaging for chewable, effervescent, and tablet formats; comparable in service scope to Innopharma though serving primarily the North American private-label and brand customer base.

Emerging players

• Bioplus Life Sciences: Contract manufacturer and private-label supplier of nutraceuticals including tablets, capsules, and powders; competes with Innopharma in third-party/private-label dietary supplement manufacturing, particularly for brands seeking lower-cost international capacity.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/innopharma-s-r-o

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innopharma